Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant therapy prematurely
- 5 March 2020
- journal article
- research article
- Published by Elsevier BV in Thrombosis Research
- Vol. 189, 61-68
- https://doi.org/10.1016/j.thromres.2020.03.001
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (T32 HL007854)
This publication has 11 references indexed in Scilit:
- Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE)Thrombosis and Haemostasis, 2018
- Antithrombotic Therapy for VTE DiseaseChest, 2016
- Anticoagulation or Inferior Vena Cava Filter Placement for Patients With Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?Stroke, 2003
- The Epidemiology of Venous ThromboembolismCell Metabolism, 2003
- The Long-Term Clinical Course of Acute Deep Venous ThrombosisAnnals of Internal Medicine, 1996
- Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein ThrombosisThrombosis and Haemostasis, 1995
- Acenocoumarol and Heparin Compared with Acenocoumarol Alone in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1992
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- One‐Month versus Six‐Month Therapy with Oral Anticoagulants after Symptomatic Deep Vein ThrombosisActa Medica Scandinavica, 1985
- Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1979